Nieuws en video's - SEER INC.

U bekijkt momenteel alle beurs nieuws van het financieel instrument SEER INC. over alle markten in alle talen.

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the fourth quarter and full year ended December 31, 2024. Recent Highlights Achieved revenue of $4.0 million for the fourth quarter of 2024 and $14.2 million for the full year 2024 Shipped 10 instruments during 2024, bringing cumulative instruments shipped to 72 as of December 31, 2024...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Participate in the TD Cowen 45th Annual Health Care Conference • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 45th Annual Healthcare Conference in Boston, MA. Seer’s management is scheduled to participate in a fireside chat on Tuesday, March 4 th at 11:50 a.m. Eastern Time / 8:50 a.m. Pacific Time. A live webcast of the session will be available on the...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will showcase new findings at the 21st Annual US Human Proteome Organization (HUPO) Conference in Philadelphia, PA, from February 22-26, 2025. As a US HUPO Conference sponsor, Seer will host a seminar highlighting novel advances in scalable deep cellular proteomics using Seer’s...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the fourth quarter and full year 2024 on Thursday, February 27, 2025. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming J.P. Morgan 43 rd Annual Healthcare Conference in San Francisco, CA. Seer’s management is scheduled to present and participate in a Q&A session on Wednesday, January 15 th at 3:00 p.m. Pacific Time / 6:00 p.m. Eastern Time. A live webcast of the session...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it ranked No. 57 on the Deloitte Technology Fast 500 ™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 30th year. Seer grew 2,440% during this period. Seer’s President and CFO, David Horn, credits...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Participate in Upcoming November Investor Conferences • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the following investor conferences: Guggenheim Inaugural Healthcare Innovation Conference in Boston, MA Fireside chat on Monday, November 11 th at 11:30 a.m. Eastern Time Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York, NY Fireside chat...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Reports Third Quarter 2024 Financial Results • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights Achieved revenue of $4.0 million for the third quarter of 2024 Entered into a co-marketing and sales agreement with Thermo Fisher Scientific to further enhance access and expand global reach to deep, unbiased proteomics at scale...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a co-marketing and sales agreement with Thermo Fisher Scientific, the world leader in serving science, to jointly promote Seer’s Proteograph™ Product Suite alongside Thermo Scientific Orbitrap Astral™ mass spectrometers. This strategic collaboration aims to accelerate the adoption of innovative proteomic...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the Proteograph Product Suite’s unique ability to deliver deep proteomic insights that complement and strengthen genomic and other “omic” research at the American Society of Human Genetics (ASHG) 2024 Annual Meeting in Denver, Colo., from Nov. 5-9. Seer will present a CoLab session exploring research...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a leading life science innovator shaping the future of proteomics, is set to present significant advancements at the 23rd Human Proteome Organization (HUPO) World Congress in Dresden, Germany, from October 20-24, 2024. As a HUPO sponsor, Seer will showcase novel findings that are driving the adoption and expansion of proteomic science, demonstrating the unique power of its Proteograph™ Product Suite to...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the third quarter 2024 on Wednesday, November 6, 2024. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s website at...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Morgan Stanley 22 nd Annual Global Healthcare Conference in New York, NY. Seer’s management is scheduled to participate in a fireside chat on Thursday, September 5 th at 4:05 p.m. Eastern Time / 1:05 p.m. Pacific Time. A live webcast of the session will...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Appoints Nicolas Roelofs to its Board of Directors • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Dr. Nicolas Roelofs to serve on its Board of Directors. “Nick is a fantastic addition to our board, bringing over 35 years of broad operational and advisory experience with leading healthcare, life science tools, and diagnostics companies,” said Omid Farokhzad, Chair and CEO of Seer....

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Canaccord Genuity 44 th Annual Growth Conference in Boston, MA. Seer’s management is scheduled to participate in a fireside chat on Wednesday, August 14 th at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. A live webcast of the session will be...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Reports Second Quarter 2024 Financial Results • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the second quarter ended June 30, 2024. Recent Highlights Achieved revenue of $3.1 million for the second quarter of 2024 Launched the Seer Technology Access Center (STAC) in Europe, providing researchers with end-to-end services from sample to data Demonstrated how the Proteograph Product...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer to Report Second Quarter 2024 Financial Results on August 8, 2024 • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter 2024 on Thursday, August 8, 2024. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s website at...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery • • GlobeNewsWire • Aandelen

Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Creation of first-of-its-kind comprehensive atlas of molecular and physiological multiomic profiles available from multiple spaceflight missions REDWOOD CITY, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced three publications highlighting studies...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma biomarker study to date utilizing the Seer Proteograph™ Product Suite and Thermo Fisher Scientific’s Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer. This pioneering research involved a multi-cancer...

Dank u Grafiek

> Nieuws GlobeNewsWire heeft een nieuws gepubliceerd.

Seer Reports First Quarter 2024 Financial Results • • GlobeNewsWire • Aandelen

REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights Achieved revenue of $3.1 million for the first quarter of 2024 Announced the expansion of the Seer Technology Access Center (STAC) program to Europe, providing researchers with end-to-end services from sample to data Further...

Dank u Grafiek